Drug Type Small molecule drug |
Synonyms DEBIO-1454, DEBIO-1454/S |
Target |
Mechanism FabI inhibitors(enoyl-ACP reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acinetobacter Baumannii Infection | Preclinical | CH | 30 Jan 2022 | |
Gram-Negative Bacterial Infections | Preclinical | CA | - | |
Healthcare-Associated Pneumonia | Preclinical | CH | - |